DISCOUNT ZERTIFIKAT - MEDTRONIC Share Price

Certificat

DE000MB5UW68

Market Closed - Börse Stuttgart 19:59:21 07/05/2024 BST
75.98 EUR +0.28% Intraday chart for DISCOUNT ZERTIFIKAT - MEDTRONIC
Current month+0.88%
1 month-1.26%
Date Price Change Volume
07/05/24 75.98 +0.28% 0
06/05/24 75.77 -0.12% 0
03/05/24 75.86 +0.85% 0
02/05/24 75.22 -0.13% 0
30/04/24 75.32 +0.17% 0

Delayed Quote Börse Stuttgart

Last update May 07, 2024 at 07:59 pm

More quotes

Static data

Product typeCertificados de Descuento
Buy / SellCALL
Underlying MEDTRONIC PLC
Issuer Morgan Stanley
WKN MB5UW6
ISINDE000MB5UW68
Date issued 26/04/2023
Maturity 21/06/2024 (45 Days)
Parity 1 : 1
Emission price 71.5
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 79.22
Lowest since issue 63.49
Spread 0.01
Spread %0.01%

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
81.9 USD
Average target price
94.77 USD
Spread / Average Target
+15.72%
Consensus